Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Details Narrative)

v3.23.1
Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Product Information [Line Items]          
Uninsured portion of balance $ 13,701,054   $ 13,701,054   $ 27,015,703
Revenue $ 86,047 131,521  
Grant [Member]          
Product Information [Line Items]          
Revenue     $ 250,000